SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-011956
Filing Date
2021-02-26
Accepted
2021-02-26 09:51:17
Documents
4
Period of Report
2021-02-25
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea136450-8k_adialpharm.htm 8-K 35557
2 PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ON FEBRUARY 25, 2021 ea136450ex99-1_adialpharm.htm EX-99.1 21119
3 GRAPHIC image_003.jpg GRAPHIC 9684
4 GRAPHIC image_006.jpg GRAPHIC 649339
  Complete submission text file 0001213900-21-011956.txt   811009
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 21684374
SIC: 2834 Pharmaceutical Preparations